TY - T1的回应SARS-CoV-2在南frica: What can we learn from drug-resistant tuberculosis? JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01369-2020 SP - 2001369 AU - Ndjeka, Norbert AU - Conradie, Francesca AU - Meintjes, Graeme AU - Reuter, Anja AU - Hughes, Jennifer AU - Padanilam, Xavier AU - Ismail, Nazir AU - Kock, Yulene AU - Master, Iqbal AU - Romero, Rodolfo AU - te Riele, Julian AU - Enwerem, Martin AU - Ferreira, Hannetjie AU - Maartens, Gary Y1 - 2020/01/01 UR - //www.qdcxjkg.com/content/early/2020/05/26/13993003.01369-2020.abstract N2 - The novel coronavirus strain, SARS-CoV-2, was first reported from China in December 2019 [1]. As of the 14th May 2020, more than 4.4 million individuals have tested positive for SARS-COV-2 globally [2]. More than 300,000 individuals have died globally due to SARS-COV-2 [2].Rapid adoption of new diagnostic tools, parallel process of research and implementation, decentralization of services, the use of personal protective equipment as well as strong partnership and collaboration could strengthen the fight against COVID-19. ER -